Skip to main content
NCBI home page
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 2019 Dec 15;30(26):3151–3160. doi: 10.1091/mbc.E19-09-0500

Genetic interactions between the DBL-1/BMP-like pathway and dpy body size–associated genes in Caenorhabditis elegans

Mohammed Farhan Lakdawala a, Bhoomi Madhu a, Lionel Faure a, Mehul Vora b, Richard W Padgett b,c,d, Tina L Gumienny a,*
Editor: Jeffrey D Hardine
PMCID: PMC6938244  PMID: 31693440

Abstract

Bone morphogenetic protein (BMP) signaling pathways control many developmental and homeostatic processes, including cell size and extracellular matrix remodeling. An understanding of how this pathway itself is controlled remains incomplete. To identify novel regulators of BMP signaling, we performed a forward genetic screen in Caenorhabditis elegans for genes involved in body size regulation, a trait under the control of BMP member DBL-1. We isolated mutations that suppress the long phenotype of lon-2, a gene that encodes a negative regulator that sequesters DBL-1. This screen was effective because we isolated alleles of several core components of the DBL-1 pathway, demonstrating the efficacy of the screen. We found additional alleles of previously identified but uncloned body size genes. Our screen also identified widespread involvement of extracellular matrix proteins in DBL-1 regulation of body size. We characterized interactions between the DBL-1 pathway and extracellular matrix and other genes that affect body morphology. We discovered that loss of some of these genes affects the DBL-1 pathway, and we provide evidence that DBL-1 signaling affects many molecular and cellular processes associated with body size. We propose a model in which multiple body size factors are controlled by signaling through the DBL-1 pathway and by DBL-1–independent processes.

INTRODUCTION

The bone morphogenetic protein (BMP) family of signaling ligands, a group within the transforming growth factor-β (TGF-β) superfamily, are used by animal cells to convey developmental and homeostatic messages. Target cells receive the secreted BMP ligands and convert the cues into cell-specific transcriptional responses. How BMP pathways control and are controlled by cells is complex and incompletely clarified. In the roundworm Caenorhabditis elegans, the BMP member DBL-1 has a well-defined pathway that includes the core components and conserved regulators, such as the negative regulator LON-2/glypican. There are clear, dose-dependent phenotypes associated with this pathway, including body size. Loss of DBL-1 signaling leads to small body size, while increased signaling results in long animals (Brenner, 1974; Savage et al., 1996; Krishna et al., 1999; Morita et al., 1999). Genetic screens and powerful molecular techniques available in C. elegans have been used to isolate, identify, and characterize DBL-1 and associated conserved BMP pathway players (Brenner, 1974; Savage et al., 1996; Krishna et al., 1999; Suzuki et al., 1999; Savage-Dunn et al., 2003; Gumienny et al., 2007, 2010; Liang et al., 2007; Gleason et al., 2017).

Previous screens for body size mutants have been done by mutagenizing otherwise wild-type animals. To increase the likelihood of identifying new modulators of the pathway, we performed a forward genetic screen using a sensitized background, lon-2(e678). Because this genotype increases DBL-1 pathway signaling and causes a long-body phenotype, we expected that we could isolate alleles that cause mild changes in body length that may not have been identified in the wild-type background used in previous screens (Brenner, 1974; Savage-Dunn et al., 2003). Suppressors were expected either to act downstream of LON-2 in the DBL-1 signaling pathway or to render animals smaller or shorter independent of DBL-1 signaling. In this screen, we identified additional genetic interactions between the BMP-like DBL-1 pathway and cellular processes and components affecting body size. Here, we analyze genetic interactions between the DBL-1 pathway and other processes that affect body size.

RESULTS AND DISCUSSION

Isolation of alleles of known DBL-1 pathway signaling components

LON-2 is a conserved glypican, a heparan sulfate proteoglycan that inhibits DBL-1 from activating its receptors (Gumienny et al., 2007). Loss of LON-2 results in increased DBL-1 pathway signaling and a long-body phenotype (Brenner, 1974). We performed an EMS mutagenesis F2 screen for animals with recessive mutations that reduce the body length of lon-2(e678) animals. We isolated and characterized 46 alleles from a screen of ∼9000 mutagenized genomes, which is less than saturation (Table 1). As expected, multiple alleles of core DBL-1 signaling pathway components were isolated (Table 1A). Two alleles of the dbl-1 gene encoding the ligand, wk91 and wk92, were confirmed by complementation testing with dbl-1(wk70). Four alleles of the gene encoding the sma-6 Type I receptor, wk87, wk103, wk129, and wk134, were confirmed by genetic testing with sma-6(e1482). Two alleles of the R-Smad sma-2 gene, wk83 and wk84, were identified by noncomplementation with sma-2(e502). The co-Smads sma-3 and sma-4 are represented in this screen by sma-3(wk107) and sma-4(wk85), confirmed by complementation testing with sma-3(e491) and sma-4(e729), respectively. Two alleles of the Smad regulator Schnurri homologue sma-9, wk97 and wk131, were shown to be allelic to sma-9(wk55). Three alleles were isolated for sma-10, a pathway regulator that interacts physically with the DBL-1 receptor complex and promotes DBL-1 pathway signaling. wk88, wk89, and wk90 did not complement sma-10(wk66) (Gumienny et al., 2010). sma-11/kin-29 is a serine–threonine kinase gene that acts genetically between dbl-1 and lon-1, a DBL-1 pathway target gene (Maduzia et al., 2005). wk117 fails to complement kin-29(wk26). Because we selected against alleles that were dauer constitutive, we did not isolate daf-4 Type I receptor mutations. These results show that this screening approach was successful for isolating DBL-1 pathway–associated alleles.

TABLE 1:

Alleles isolated in an EMS screen that suppress the lon-2(e678) long body size.

Gene Known allele Function or homology (Drosophila) Allele isolated
A. Alleles of DBL-1 pathway genes
dbl-1 wk70 TGF-β-like ligand wk91, wk92
sma-6 e1482 Type I receptor wk87, wk103, wk129, wk134
sma-2 e502 Smad wk83, wk84
sma-3 e491 Smad wk107
sma-4 e729 Smad wk85
sma-9 wk55 Transcription regulator (Schnurri) wk97, wk131
sma-10 wk66 LRIG (binds receptors to facilitate signaling) wk88, wk89, wk90
kin-29/sma-11 wk26 Kinase wk117
B. Alleles of uncloned sma genes
sma-12 wk69 Positive body size effector wk119
sma-13 wk52 Positive body size effector wk109
— - Positive body size effector wk94
— - Positive body size effector wk98
— - Positive body size effector wk123
C. Alleles of ECM-associated genes
dpy-1 e1 Mucin-like wk111, wk142, wk143
dpy-2 e8 Collagen (Viking) wk104, wk122
dpy-3 e27 Collagen (Col4a1) wk105
dpy-4 e1166 Collagen (Col4a1) wk101, wk102
dpy-5 e61 Collagen (Col4a1) wk137
dpy-6 e14 Mucin-like wk113, wk118, wk127, wk132
dpy-7 e88 SFTPD (collagen-containing C-type lectin) (Col4a1) wk106
dpy-8 e130 Collagen (Viking) wk120
dpy-9 e12 Collagen (Col4a1) wk124
dpy-13 e184 Collagen (Viking) wk95, wk135, wk145
dpy-14 e188 Collagen (Viking) wk116, wk128
dpy-17 e164 Collagen (Viking) wk140
D. Alleles of other body size-associated genes
dyf-11 wk57 Intraflagellar transport particle B component (IFT54) wk136, wk139
dpy-20 e1282 BED zinc finger protein wk141
Open in a new tab

Isolation and mapping of alleles of unknown loci

This screen also provided additional alleles of uncloned genes (Table 1B). wk119 is allelic to sma-12(wk69) V, and wk109 is allelic to sma-13(wk52) I (Savage-Dunn et al., 2003). Three loci remain unnamed. Another allele, wk94, was mapped to chromosome II and complements sma-6, dpy-2, and dpy-10. It is slow-growing. wk123 also maps to Chromosome II and complements sma-6, dpy-2, dpy-10, and wk94. wk98 maps to Chromosome III and is not allelic to daf-4, sma-2, sma-3, sma-4, or sma-17(wk59). wk98 males have a normal male tail and mate well, unlike most alleles of DBL-1 core-pathway genes.

Isolation of alleles of extracellular matrix–associated genes

Many gene products contribute to the C. elegans cuticle, a specialized extracellular matrix (ECM) that protects animals. Loss of some cuticle-associated genes produces a reduced body size (Page and Johnstone, 2007). Alleles of several collagen genes were isolated in the lon-2 suppressor screen (Table 1C). These loci were identified by their failure to complement published dpy alleles (see Table 1 for alleles tested). wk116 and wk128 are alleles of collagen type III alpha 1-like gene dpy-14. Alleles of genes encoding proteins with collagen domains were isolated: dpy-2 (wk104 and wk122), dpy-3/dpy-12 (wk105), dpy-4 (wk101 and wk102), dpy-5 (wk137), dpy-7 (wk106), dpy-8 (wk120), dpy-9/col-100 (wk124), dpy-13 (wk95, wk135, and wk145), and dpy-17 (wk140).

The screen also produced alleles of two mucin-like genes, dpy-1 (wk111, wk142, and wk142) and dpy-6 (wk113, wk118, wk127, and wk132; Table 1C; S. Eimer, personal communication, July 18, 2019; Shen et al., 2008). Mucins are glycosylphosphatidylinositol (GPI)-anchored cell surface glycoproteins that are components of the C. elegans cuticle’s surface coat. In other systems, mucins are transcriptionally regulated by the TGF-β pathway (Jonckheere et al., 2004a,b). Human mucin 1 is required for TGF-β expression, secretion, and activity (Li et al., 2015a,b; Grover et al., 2018).

Isolation of alleles of other body size–associated genes

Loss of some intraflagellar transport (IFT) components is associated with a reduced body size (Starich et al., 1995; Kobayashi et al., 2007). We discovered that wk136 and wk139 are allelic to dyf-11(mn392), which produces “slightly short” animals and affects a protein related to TRAF3IP1 (TRAF3 interacting protein 1)/MIP-T3 (microtubule-interacting protein that interacts with TRAF3, the tumor necrosis factor receptor–associated factor 3). MIP-T3 is associated with intraflagellar transport particle B, a complex that transports cargo to the tip of flagella and cilia (Starich et al., 1995; Bacaj et al., 2008). wk139 and wk136 are also allelic to previously uncloned sma-16(wk57), which has a similar mild small body size phenotype (Table 1D; Savage-Dunn et al., 2003). This result suggests that the small body size associated with loss of IFT suppresses DBL-1 pathway-mediated body size. Future work will determine whether the mechanism of this body size suppression is independent of DBL-1 signaling.

dpy-20 encodes a novel BED zinc-finger protein required for normal body morphology, movement, male mating (but not ray morphology), and germ cell proliferation (Hodgkin, 1983; Baird and Emmons, 1990; Clark et al., 1995; Schertel and Conradt, 2007; Yemini et al., 2013). A role as a transcription regulator, a common (but not exclusive) role for other BED zinc-finger-containing proteins, has been suggested for DPY-20 (Aravind, 2000). Transcriptional regulation of cuticle genes by DPY-20 is supported by observed changes in cuticle structure in animals with absent or reduced levels of DPY-20 (Clark et al., 1995). An allele of dpy-20, wk141, was isolated in the lon-2 suppressor screen (Table 1D). In addition to the dumpy body shape, wk141 animals also displayed a round head characteristic of dpy-20 (unpublished data; Clark et al., 1995).

Loss of dpy gene function reduces body size of animals overexpressing DBL-1

LON-2 is a glypican that normally sequesters DBL-1 ligand and prevents DBL-1 from activating receptors that mediate body size gene expression (Gumienny et al., 2007). Loss of LON-2 results in long animals (Brenner, 1974). Overexpressing DBL-1 also results in long animals (Morita et al., 1999; Schultz et al., 2014). To generate a more comprehensive understanding of the interaction of DBL-1 signaling with other factors that have strong effects on body size, we asked whether loss of the function of a panel of genes affecting body size in C. elegans can suppress the long body size defect exhibited by animals overexpressing DBL-1. This panel includes all dpy genes identified in the screen and dpy-10, dpy-11, sqt-3/dpy-15, dpy-18, dpy-19, dpy-21, dpy-23, and blmp-1/dpy-24, for which alleles were not isolated. Regardless of gene function, most dpy(RNAi)s and all dpy mutants tested in green fluorescent protein (GFP)-tagged DBL-1 overexpressing backgrounds are significantly shorter than the controls (Supplemental Table S2). Thus, all dpy mutants tested suppress the long phenotype associated with overexpressed GFP-tagged DBL-1.

Some extracellular matrix–associated genes interact genetically with the DBL-1 pathway

In C. elegans, signaling by the DBL-1 pathway controls components that form the cuticle, a specialized ECM that not only provides a barrier between the animal and its environment, but also affects the size of the organism within it (Mochii et al., 1999; Liang et al., 2007; Luo et al., 2009; Roberts et al., 2010; Madaan et al., 2018). Possibly because the C. elegans cuticle is dynamic, with different constituents composing the cuticle of each of its developmental stages, different cuticle component genes were identified in these studies. Altering the cuticle content by reduced DBL-1 signaling may underlie dbl-1 loss-of-function phenotypes besides smaller body length, including male tail ray fusions, increased cuticular permeability, and “worm-star” formation by clusters of nematodes becoming entangled by their tails (Savage et al., 1996; Morita et al., 1999; Suzuki et al., 1999; Schultz et al., 2014). However, loss of single cuticular proteins can also alter nematode body length, possibly independent of the DBL-1 pathway (Brenner, 1974; Nystrom et al., 2002; Page and Johnstone, 2007; Fernando et al., 2011).

We tested for interaction of selected genes with the DBL-1 pathway in two ways. First, we used a functional GFP-tagged DBL-1 (GFP::DBL-1) translational reporter (dbl-1p::gfp::dbl-1) to determine whether dpy gene products affect the DBL-1 ligand. Second, we used a transcriptional reporter for DBL-1 pathway activity, GFP expressed from the spp-9 promoter (spp-9p::gfp). spp-9 is a negatively regulated transcriptional target of the DBL-1 pathway that encodes a saposin-like protein, an innate immune response factor (Roberts et al., 2010).

We tested these two reporters against dpy genes that encode structural components of the extracellular matrix. RNA interference (RNAi) of these genes in the GFP::DBL-1 background suggested that many affect DBL-1 ligand (Supplemental Table S3). We crossed these reporter transgenes into the panel of dpy mutants and examined their effect on reporter expression in 24-h adult hermaphrodites. Interestingly, all tested ECM mutants that significantly reduced GFP::DBL-1 fluorescence levels also affected spp-9p::gfp expression (Table 2B). This result confirms spp-9p::gfp reporter activity is strongly linked to the DBL-1 pathway.

TABLE 2:

Effects of body size–associated genes on GFP::DBL-1 and DBL-1 pathway reporter spp-9p::GFP fluorescence.

Gene Genotype dbl-1::gfp ­fluorescence % control ± 95% CI p value Genotype spp-9p::GFP fluorescence % control ± 95% CI p value
A. Controls
Control texIs100 100 ± 15.57 texIs127 100 ± 11.47
Control texIs101 100 ± 25.95 wkIs40 100 ± 13.20
B. ECM-associated genes
dpy-1 dpy-1(e1); texIs100 96.02 ± 40.89 0.8335 dpy-1(e1); texIs127 100.80 ± 16.97 0.9234
dpy-2 dpy-2(e8); texIs100 115 ± 52.15 0.5080 dpy-2(e8); texIs127 107.04 ± 12.20 0.2344
dpy-3 texIs100; dpy-3(e27) 43.45 ± 21.63 0.0012 wkIs40; dpy-3(e27) 156.26 ± 16.06 0.0001
dpy-4 dpy-4(e1166); texIs101 102.24 ± 28.06 0.9043 dpy-4(e1166); texIs127 125 ± 25.16 0.0192
dpy-5 dpy-5(e61); texIs100 54.13 ± 26.47 0.0127 dpy-5(e61); texIs127 155.23 ± 25.16 0.0001
dpy-6 texIs101; dpy-6(e14) 59.96 ± 17.12 0.0009 wkIs40; dpy-6(e14) 179.04 ± 19.77 0.0001
dpy-7 texIs100; dpy-7(e88) 79.88 ± 34.85 0.2689 wkIs40; dpy-7(e88) 104.89 ± 12.95 0.4299
dpy-8 texIs100; dpy-8(e130) 79.64 ± 26.74 0.1828 wkIs40; dpy-8(e130) 92.68 ± 11.12 0.2061
dpy-9 dpy-9(e12); texIs101 95.02 ± 29.01 0.7248 dpy-9(e12); texIs127 100.29 ± 10.24 0.9533
dpy-10 dpy-10(e128); texIs100 61.46 ± 2 4.99 0.0172 dpy-10(e128); texIs127 115.50 ± 11.56 0.0054
dpy-11 texIs100; dpy-11(e224) 92.10 ± 28.95 0.6094 dpy-11(e224); texIs127 128.88 ± 18.06 0.0007
dpy-13 dpy-13(e184); texIs101 91.98 ± 30.42 0.5829 dpy-13(e184); texIs127 156.65 ± 24.39 0.0001
dpy-14 dpy-14(e188); texIs100 64.97 ± 2 6.13 0.0289 dpy-14(e188); texIs127 142.81 ± 22.04 0.0001
dpy-15 texIs100; dpy-15(e24) 99.14 ± 43.40 0.9654 dpy-15(e24); texIs127 86.33 ± 19.32 0.1875
dpy-17 dpy-17(e164); texIs100 80.99 ± 29.16 0.1969 dpy-17(e164); texIs127 121.07 ± 17.84 0.0116
dpy-18 dpy-18(e364); texIs100 96.43 ± 36.45 0.8543 dpy-18(e364); texIs127 110.60 ± 15.13 0.1336
C. Other body size–associated genes
dpy-19 dpy-19(e1259); texIs100 109.22 ± 47.09 0.6514 dpy-19(e1259); texIs127 132.90 ± 29.35 0.0107
dpy-20 dpy-20(e1282); texIs101 91.56 ± 54.19 0.7181 dpy-20(e1282); texIs127 109.77 ± 15.57 0.1818
dpy-21 texIs100; dpy-21(e428) 110.37 ± 44.89 0.6011 dpy-21(e428); texIs127 116.86 ± 11.93 0.0033
dpy-23 texIs100;dpy-23(e840) 39.87 ± 14.82 0.0005 wkIs40;dpy-23(e840) 120.47 ± 13.55 0.0015
dpy-24 dpy-24(s71); texIs100 59.89 ± 22.45 0.0182 dpy-24(s71); texIs127 135.42 ± 19.64 0.0001
Open in a new tab

Some extracellular matrix–associated genes had no effect on either GFP::DBL-1 or spp-9p::gfp expression: dpy-1/mucin and dpy-2, dpy-7, dpy-8, dpy-9, and sqt-3/dpy-15 (Figure 1 and Table 2B). These results are consistent with these gene products having no effect on DBL-1 signaling. dpy-3, dpy-5, dpy-6, dpy-10, and dpy-14 decreased GFP::DBL-1 fluorescence and increased spp-9p::gfp expression, consistent with loss of these gene products having a negative impact on DBL-1 signaling, suggesting feedback. Interestingly, other specific collagens that are DBL-1–regulated also show this feedback on DBL-1 signaling (Madaan et al., 2019).

FIGURE 1:

FIGURE 1:

Open in a new tab

Effects of ECM-associated gene mutations on GFP::DBL-1 and DBL-1 pathway reporter spp-9p::GFP fluorescence. Arrows point to GFP::DBL-1 fluorescent punctae in A–R. Representative images show adult hermaphrodite expression of GFP::DBL-1 (A–R) and spp- 9p::GFP (A′–R′) in the following mutant backgrounds: A and B, wild type; C, dpy-1; D, dpy-2; E, dpy-3; F, dpy-4; G, dpy-5; H, dpy-6; I, dpy-7; J, dpy-8; K, dpy-9; L, dpy-10; M, dpy-11; N, dpy-13; O, dpy-14; P, sqt-3/dpy-15; Q, dpy-17; R, dpy-18; dpy mutants that reduced GFP-tagged DBL-1 and increased spp-9p::GFP activity are shown in E, G, H, L, and O. dpy mutants that increased spp-9p::GFP reporter activity without affecting GFP-tagged DBL-1 are shown in F, M, N, and Q. dpy mutants that had no effect on either of the reporters are shown in C, D, I, J, K, P, and R. Bars in A and B represent 10 and 100 μm, respectively.

Notably, we discovered that dpy-4, dpy-13, and dpy-17 significantly up-regulate spp-9p::gfp expression without affecting GFP::DBL-1 fluorescence (Figure 1; Table 2B). C. elegans DPY-17 is predicted to act downstream of DBL-1 secretion (Fotopoulos et al., 2015). In other systems, basement membrane collagens bind BMPs and enhance their interaction with receptors, promoting downstream signaling (Paralkar et al., 1990, 1992; Wang et al., 2008). However, DPY-4, DPY-13, and DPY-17 are predicted cuticle collagens and therefore probably do not act between the secreting and receiving cells (see Figure 3 later in the paper). It is possible that these collagens indirectly regulate DBL-1 signaling targets by affecting the cuticle. Also, while loss of some collagen genes, including dpy-2 and dpy-7, induced a robust stress response in C. elegans, loss of dpy-4 and dpy-13 failed to do so (Dodd et al., 2018). The significant increase of spp-9p::gfp expression in dpy-4 and dpy-13, but not in dpy-2 or dpy-7, also supports the conclusion that spp-9p::gfp is strongly responsive to DBL-1 signaling and not to stress by cuticle alteration. Nonetheless, we show specificity of collagen regulation of DBL-1 signaling, because some known cuticle collagens have no effect on DBL-1 signaling in one-day adults (DPY-2, DPY-7, DPY-9, and SQT-3/DPY-15). It should be noted, though, that some collagens are known to be expressed at certain stages in C. elegans, so some ECM-associated dpy genes may affect DBL-1 signaling at other stages, which we would not have identified in this study (Celniker et al., 2009; Jackson et al., 2014; Madaan et al., 2019).

FIGURE 3:

FIGURE 3:

Open in a new tab

Proposed model of body size regulation by the DBL-1 pathway and dpy body size–associated genes in C. elegans. Within the sending cell, DBL-1 may be modified by DPY-19/C-mannosyltransferase and transported by the AP2 complex, which includes the DPY-23/AP2 mu subunit. Signaling through the receptor complex may also be controlled by DPY-23. DBL-1 signaling directly controls the expression of cuticle components, which affects body size (arrow 1). DPY-11/disulfide oxidoreductase may process DBL-1-regulated cuticle components before secretion. DBL-1–regulated gene expression, in part through BLMP-1, may modulate signaling within the receiving cell (arrow 2) or between the sending and receiving cells (arrow 3), or may feed back on the sending cell (arrow 4). Cues from the receiving cell or cuticle may be received (indirectly) by the sending cell and affect DBL-1 expression or secretion (arrow 5) or affect signaling downstream of DBL-1 secretion (starred arrowhead in arrow 5 and starred DPY collagens). Other cell-signaling pathways act independent of DBL-1 to control body size (arrow 6). Dashed lines represent potential indirect regulation. dpy gene products that had no effect on DBL-1 signaling are not included in this model.

In addition, we tested these two reporters against two dpy genes that encode ECM-processing enzymes. DPY-18 is a prolyl-4-hydroxylase alpha catalytic subunit, which in other organisms is required for collagen secretion as well as triple-helix assembly and stability (Mazzorana et al., 1993; Brodsky and Ramshaw, 1997; Walmsley et al., 1999; Hill et al., 2000). dpy-11 encodes a hypodermally expressed disulfide oxidoreductase that is predicted to modify extracellular matrix constituents (Nishiwaki and Miwa, 1998; Ko and Chow, 2002). Based on their phenotypes, both of these gene products may affect both cuticle and basement membrane (Nishiwaki and Miwa, 1998; Hill et al., 2000; Ko and Chow, 2002; Torpe and Pocock, 2014). dpy-18 loss had no effect on either DBL-1 pathway reporter, but dpy-11 loss affected spp-9p::GFP without affecting the ligand within the secreting cell (Figure 1; Table 2B).

Together, these results suggest that the DBL-1 pathway and spp-9 target gene expression are sensitive to cuticle-related factors that indirectly impact DBL-1 signaling.

Other body size genes interact genetically with the DBL-1 pathway

dpy-19 encodes a C-mannosyltransferase (Buettner et al., 2013). dpy-19(e1259) resulted in significantly higher spp-9p::gfp reporter activity but did not alter GFP-tagged DBL-1 fluorescence levels (Figure 2; Table 2C). This enzyme family recognizes W-x-x-W motifs and adds α-mannose to the tryptophans in these motifs. C. elegans DBL-1 has a conserved W-x-x-W motif and may be a direct target of DPY-19. However, ADAMTS protease ADT-2/SMA-21 regulates DBL-1 signaling positively, and ADAMTS proteases are also targets of this enzyme family (Fernando et al., 2011; Ihara et al., 2015). ADT-2/SMA-21 isoforms have up to seven W-x-x-W or W-x-x-W-x-x-W motifs (Fernando et al., 2011). Therefore, DPY-19 may regulate DBL-1 signaling directly through DBL-1′s W-x-x-W motif, which may not affect DBL-1 localization within secreting cells but may affect DBL-1′s ability to activate its receptors. Alternatively, DPY-19 may regulate DBL-1 signaling indirectly through modification of an ADAMTS protease.

FIGURE 2:

FIGURE 2:

Open in a new tab

Effects of other body size–associated gene mutations on GFP::DBL-1 and DBL-1 pathway reporter spp-9p::GFP fluorescence. Arrows point to GFP::DBL-1 fluorescent punctae in A–E. Representative images show adult hermaphrodite expression of GFP::DBL-1 (A–E) and spp-9p::GFP (A′–E′) in the following mutant backgrounds: A, dpy-19; B, dpy-20; C, dpy-21; D, dpy-23; E, dpy-24. Compare to controls in Figure 1. dpy mutants that reduced GFP-tagged DBL-1 and increased spp-9p::GFP activity are shown in D and E. dpy mutants that increased spp-9p::GFP reporter activity without affecting GFP-tagged DBL-1 are shown in A and C. A dpy mutant that had no effect on either of the reporters is shown in B. Bars in A and B represent 10 and 100 μm, respectively.

Some sex and dosage compensation mutants are also shorter, perhaps from overexpression of X-linked body size genes (Meyer, 2005). We tested one of these, dpy-21, a dosage compensation–complex subunit (Yonker and Meyer, 2003). Loss of dpy-21 increased DBL-1 pathway reporter expression but did not affect the GFP-tagged DBL-1 ligand (Figure 2; Table 2C).

dpy-23/apm-2 encodes the adaptor protein complex 2 (AP2) mu subunit. dpy-23(e840), a 100-kb deletion that removes 18 open reading frames, significantly reduces GFP-tagged DBL-1 fluorescence and increases reporter activity (Figure 2; Table 2C; Gu et al., 2008). DPY-23 is involved in protein trafficking, including the trafficking of the DBL-1 receptor SMA-6, which affects DBL-1 signaling (Gleason et al., 2014). Feedback caused by loss of the DBL-1 receptor SMA-6 at the membrane could decrease ligand expression. However, DPY-23 is also expressed in the same neurons as DBL-1 and may play a direct role in the secretion of DBL-1 (Shim and Lee, 2000). While all phenotypes associated with e840 deletion are fully rescued by expression of wild-type dpy-23, it is possible that the DBL-1–associated phenotypes identified here are caused by a different part of the e840 deletion (Gu et al., 2008).

Two putative transcription factor genes also were tested. Loss of the BED zinc-finger protein gene dpy-20 had no effect on GFP-tagged DBL-1 fluorescence or spp-9 transcriptional reporter expression (Figure 2; Table 2C). However, loss of the SET domain and the zinc-finger protein gene blmp-1/dpy-24 significantly reduced GFP-tagged DBL-1 fluorescence and increased spp-9 transcriptional reporter expression (Figure 2; Table 2C). This result supports a genetic interaction between BLMP-1 and the DBL-1 pathway. Another C. elegans superfamily member related to DBL-1, daf-7, requires blmp-1 for proper signaling (Hyun et al., 2016). In mammals, BLIMP1 is highly regulated by the TGF-β pathway (Salehi et al., 2012; Telerman et al., 2017).

Regulation of body size–associated genes by DBL-1

TGF-β pathways regulate ECM genes in many systems, both directly and indirectly (Morikawa et al., 2011; Kim et al., 2018; Madaan et al., 2018). In C. elegans, microarray analyses showed that some ECM genes are highly regulated by this pathway (Mochii et al., 1999; Liang et al., 2003; Roberts et al., 2010). Furthermore, ChIP-seq analyses showed that the DBL-1 pathway signal transducer SMA-3 binds the regulatory region of the cuticle collagen genes col-141 and col-142 (Madaan et al., 2018). To better understand the interplay between the DBL-1 pathway and other body size players, we performed RNA-seq analyses on wild-type and dbl-1(nk3) strains. Like previous microarray results, we identified several cuticle-associated genes that were down-­regulated in the dbl-1(nk3) strain as compared with the wild type (Supplemental Table S4). However, our panel of regulated genes is overlapping but more extensive. In addition, we identified SMA-3 binding sites upstream of body size–associated genes by interrogating the SMA-3 MODENCODE data set (Gerstein et al., 2010). We also determined that blmp-1 is highly regulated by DBL-1. Notably, SMA-3 binds within 1000 bp upstream of blmp-1, suggesting that C. elegans BLMP-1 is transcriptionally regulated by DBL-1/BMP, as seen by TGF-β regulation of BLIMP1 in other systems (Gerstein et al., 2010; Salehi et al., 2012; Telerman et al., 2017). BLMP-1 binds upstream of most of the ECM-associated genes that are differentially regulated by DBL-1, suggesting that DBL-1 signaling regulates these ECM genes through transcriptional control of BLMP-1 (Supplemental Table S4) (Gerstein et al., 2010). It remains to be experimentally determined whether this correlation is physiologically relevant.

Concluding remarks

In this work, we have presented the analysis of a lon-2(-) suppressor screen and a related panel of body size–associated dpy genes. We have identified complex interactions between DBL-1 signaling and other body size regulators, which have previously been presumed to act independent of DBL-1 signaling. This work supports the model that the DBL-1 pathway is a master regulator of several processes that together affect the body size trait, and some body size–associated genes also feed back on the DBL-1 pathway (Figure 3; Mochii et al., 1999; Roberts et al., 2010; Liang et al., 2013; Madaan et al., 2018, 2019). Some DBL-1 pathway suppressors and other body size–associated genes may be regulated directly by the DBL-1 pathway Smads. However, expression of other body size–associated genes may be controlled by DBL-1–regulated transcription factors such as BLMP-1/DPY-24. We are poised to define the molecular and cellular relevance of the genetic interactions between DBL-1 signaling and other body size regulators, including the uncloned loci, DPY-6/mucin-like protein, intraflagellar transport proteins, DPY-19/C-mannosyltransferase, and BLMP-1/DPY-24/transcription regulator.

MATERIALS AND METHODS

Strains and maintenance

C. elegans strains used in these studies were derived from the wild-type variety Bristol strain N2 and were cultured on modified EZ nematode growth media plates as previously described (Madhu et al., 2019). All strains were cultured on Escherichia coli strain OP50 at 20°C. Strains generated and used are listed in Supplemental Table S1. Double mutant lines were generated using standard genetic crosses.

The transgenic alleles texIs100 [dbl-1::dbl-1:gfp; ttx-3p::rfp] IV and texIs101 [dbl-1::dbl-1:gfp; ttx-3p::rfp] V were created by UV/TMP mutagenesis of an extrachromosomal array (Beifuss and Gumienny, 2012). wkEx52 (spp-9p::gfp) was integrated using an established UV/TMP mutagenesis procedure to yield texIs127 X (Yandell et al., 1994). These integrated transgenes were backcrossed five times and mapped. wkEx52(spp-9p::gfp) was integrated into N2 animals using an x-ray source to yield wkIs40. This strain was backcrossed four times to the N2 wild-type strain. The resulting strain was named LT998.

Double mutants with texIs100, texIs101, texIs127, and wkIs40, and the triple mutant strain TLG281 rrf-3(pk1426) II; texIs100 IV; dbl-1(nk3) V were constructed by standard methods (Supplemental Table S1) (Brenner, 1974). A complete list of strains used in this work is provided in Table 1 and Supplemental Table S1.

Forward genetic screen for suppressors of the lon-2(e678) long phenotype

To identify factors involved in regulating DBL-1 pathway-mediated body length, lon-2(e678) hermaphrodites were mutagenized with 50 mM ethyl methanesulfonate (EMS) as previously described (Brenner, 1974; Savage-Dunn et al., 2003). Mutagenized animals were transferred to plates to self-propagate. F1 animals were transferred two to a plate to self. F2 populations were scored for a reduced body length in about one-eighth of the population, assuming a recessive mutation. Only one animal from each plate containing a candidate mutant was maintained, to confirm that each candidate was independently obtained. About 9000 mutagenized genomes were scored (less than saturation), and lines with high body size–phenotype penetrance and expressivity, and with good health, were selected for characterization. Animals that showed other phenotypes, including rolling movement (Rol) and reduced viability or sterility, were excluded. Mutants were outcrossed five times to N2 before further analyses. Outcrossing also identified whether alleles resided on the X chromosome or an autosome. Mutations were complementation-tested for allelism with known DBL-1 pathway genes. Alleles of novel loci were then tested for linkage to STS markers or to unc-15(e73) I, unc-104(e1265) II, unc-32(e189) III, unc-5(e53) IV, and unc-23(e25) V (Williams et al., 1992). Next, mutations mapping to the same linkage group were complementation-tested to each other and candidate gene mutant alleles. Some alleles were further mapped using standard two-factor, three-factor, and SNP mapping techniques (Brenner, 1974; Wicks et al., 2001).

RNA interference

RNAi by bacterial feeding was performed as previously described (Timmons and Fire, 1998). The C. elegans strain TLG281 rrf-3(pk1426) II; texIs100 IV; dbl-1(nk3) V was used for this experiment (Beifuss and Gumienny, 2012). Bacteria from the Vidal and Ahringer cDNA libraries (Open Biosystems and Source BioScience, respectively) were used (Kamath and Ahringer, 2003; Rual et al., 2004). C06C3.5, a predicted pseudogene, was used as the negative control. bli-4(RNAi) was used as the positive control (Thacker et al., 1995). Bacteria from single colonies were grown overnight in Luria–Bertani broth (Sigma, St. Louis, MO) containing 50 µg/ml carbenicillin (Gold Biotechnology, St. Louis, MO) and induced to express dsRNA using 1 µg/ml isopropyl β-d-1-thiogalactopyranoside (IPTG) for 4 h. After induction, bacterial broth was plated on nematode growth medium containing 50 µg/ml carbenicillin and 1 µg/ml IPTG and dried. Embryos staged by bleaching were transferred to these plates and grown to the young adult stage for observation as previously described (Kamath and Ahringer, 2003; Rual et al., 2004; Beifuss and Gumienny, 2012).

Imaging

C. elegans adults 24 h post-L4 were anesthetized using 1 mM levamisole hydrochloride (Sigma, St. Louis, MO) for fluorescence and body size imaging.

Fluorescence imaging

Fluorescence imaging for RNAi and mutant studies was performed using a Nikon A1 confocal system (Nikon Instruments, Melville, NY). A 60× objective was used to capture GFP::DBL-1 intensities. Fluorescence intensities of spp-9p::gfp were captured using a 10× objective. Microscope settings were standardized to obtain fluorescence intensity values in the measurable dynamic range for both control and experimental samples, and these image-capture conditions were kept constant throughout the experiments. Mean fluorescence intensities were measured using Nikon NIS Elements AR-5.02 software.

Body size imaging

For RNAi studies, animals were imaged using the same confocal system with a 10× objective to measure their body length. Body size was quantified using NIS Elements AR-5.02 imaging software.

For mutant studies, animals were imaged to measure body size using a Nikon SMZ1500 dissecting microscope (Nikon, Melville, NY). Body size was measured using the length measurement image tool within iVision-Mac (BioVision Technologies, Exton, PA).

RNA-seq

We used two biological replicates of wild-type and dbl-1(nk3) populations for RNA sequencing with the Illumina MiSeq system. Animals were staged by bleaching and harvested for RNA extraction at the 48 h post-L4 stage. RNA extraction was performed using the freeze-cracking method as previously described (Portman, 2006). A total of 2 µg of total RNA of each sample was used for TruSeq Stranded mRNA sample preparation using the low sample protocol per manufacturer’s instructions (Illumina). RNA and cDNA concentrations were measured by a Qubit fluorometer (Molecular Probes, Life Technologies). The quality of RNA and cDNA was assessed by an Experion automated electrophoresis system (BioRad). The libraries were sequenced with ∼40–50 million total reads and FASTQ quality scores of the raw data from sequencing were generated. The reads were mapped against the C. elegans genome ce10 (UCSC RefSeq gene annotation) using the STAR aligner (RNA-Seq Alignment, Illumina). On the average, 97.9% of reads were aligned. Cufflinks 2 was used for the FPKM estimation of reference genes and transcripts. Differential gene expression analysis was performed with Cuffdiff2 using the Cufflinks Assembly and DE application (Illumina). Candidates with a q value <0.05 were classified as differentially expressed genes.

Statistical analysis

We used at least seven animals to quantify GFP::DBL-1 fluorescence and at least 10 animals to measure body size for RNAi studies. For the mutant studies, we used at least 10 animals to quantify GFP::DBL-1 fluorescence intensities and at least 15 animals to measure spp-9p::gfp fluorescence intensities. We used at least 30 animals to determine body size for the mutant studies. Mean fluorescence intensities and body length values of test populations were calculated as percentages of their respective controls with 95% confidence intervals. Statistical analyses were performed using an independent t test to compare test and control sample means.

Data and reagent availability

Strains listed in Table 1 and Supplemental Table S1 are available upon request.

Supplementary Material

Click here for additional data file. (43.8KB, pdf)

Acknowledgments

We thank Lisa Maduzia, Huang Wang, Adam Auerbach, James Cignarella, Lena Chin, Steven Cohen, and Archna Sinha for mutant screening. We thank Bryce Chiang, Naomi Klassel, Andrew Roberts, Tara Wahab, Shi-Lan Wu, and Cole Zimmerman for complementation testing and/or mapping. Aileen Salazar created some double mutant strains. Stefan Eimer provided dpy-1 cloning information. We thank Cathy Savage-Dunn and members of the Padgett lab, including Luke Huggins and Pradeep Das, and the Gumienny lab, including Geethanjali Ravindranathan, Sanil Sansar, and Neethu Issac, for constructive discussion. Sujata Agarwal designed the Figure 3 model. Pamela Padilla provided some RNAi constructs. Some strains were obtained from the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). We thank WormBase. This work was supported by National Institutes of Health grants F32 GM066445, T32-MH/AG19957-06A2, and R01 GM097591, a Charles and Johanna Busch Postdoctoral Fellowship, and a TWU Chancellor’s Research Fellowship to T.L.G., and internal funding by Texas Woman’s University. This work is dedicated to family and friends.

Abbreviations used:

ADAMTS

a disintegrin and metalloproteinase domain with thrombospondin motif

BMP

bone morphogenetic protein

ECM

extracellular matrix

EMS

ethyl methanesulfonate

GFP

green fluorescent protein

GPI

glycosylphosphatidylinositol

IFT

intraflagellar transport

IPTG

isopropyl β- d-1-thiogalactopyranoside

RNAi

RNA interference

TGF-β

transforming growth factor-β

Footnotes

This article was published online ahead of print in MBoC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E19-09-0500) on November 6, 2019.

REFERENCES

  1. Aravind L. (2000). The BED finger, a novel DNA-binding domain in chromatin-boundary-element-binding proteins and transposases. Trends Biochem Sci , 421–423. [DOI] [PubMed] [Google Scholar]
  2. Bacaj T, Lu Y, Shaham S. (2008). The conserved proteins CHE-12 and DYF-11 are required for sensory cilium function in Caenorhabditis elegans . Genetics , 989–1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baird SE, Emmons SW. (1990). Properties of a class of genes required for ray morphogenesis in Caenorhabditis elegans . Genetics , 335–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beifuss KK, Gumienny TL. (2012). RNAi screening to identify postembryonic phenotypes in C. elegans J Vis Exp , e3442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brenner S. (1974). The genetics of Caenorhabditis elegans . Genetics , 71–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brodsky B, Ramshaw JA. (1997). The collagen triple-helix structure. Matrix Biol , 545–554. [DOI] [PubMed] [Google Scholar]
  7. Buettner FF, Ashikov A, Tiemann B, Lehle L, Bakker H. (2013). C. elegans DPY-19 is a C-mannosyltransferase glycosylating thrombospondin repeats. Mol Cell , 295–302. [DOI] [PubMed] [Google Scholar]
  8. Celniker SE, Dillon LA, Gerstein MB, Gunsalus KC, Henikoff S, Karpen GH, Kellis M, Lai EC, Lieb JD, MacAlpine DM, et al (2009). Unlocking the secrets of the genome. Nature , 927–930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clark DV, Suleman DS, Beckenbach KA, Gilchrist EJ, Baillie DL. (1995). Molecular cloning and characterization of the dpy-20 gene of Caenorhabditis elegans . Mol Gen Genet , 367–378. [DOI] [PubMed] [Google Scholar]
  10. Dodd W, Tang L, Lone JC, Wimberly K, Wu CW, Consalvo C, Wright JE, Pujol N, Choe KP. (2018). A damage sensor associated with the cuticle coordinates three core environmental stress responses in Caenorhabditis elegans . Genetics , 1467–1482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fernando T, Flibotte S, Xiong S, Yin J, Yzeiraj E, Moerman DG, Meléndez A, Savage-Dunn C. (2011). C. elegans ADAMTS ADT-2 regulates body size by modulating TGFβ signaling and cuticle collagen organization. Dev Biol , 92–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fotopoulos P, Kim J, Hyun M, Qamari W, Lee I, You YJ. (2015). DPY-17 and MUA-3 interact for connective tissue-like tissue integrity in Caenorhabditis elegans: a model for Marfan syndrome. G3 (Bethesda) , 1371–1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerstein MB, Lu ZJ, Van Nostrand EL, Cheng C, Arshinoff BI, Liu T, Yip KY, Robilotto R, Rechtsteiner A, Ikegama K, et al (2010). Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science , 1775–1787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gleason RJ, Akintobi AM, Grant BD, Padgett RW. (2014). BMP signaling requires retromer-dependent recycling of the type I receptor. Proc Natl Acad Sci USA , 2578–2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gleason RJ, Vora M, Li Y, Kane NS, Liao K, Padgett RW. (2017). C. elegans SMA-10 regulates BMP receptor trafficking. PLoS One , e0180681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grover P, Nath S, Nye MD, Zhou R, Ahmad M, Mukherjee P. (2018). SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line. Oncotarget , 6897–6910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gu M, Schuske K, Watanabe S, Liu Q, Baum P, Garriga G, Jorgensen EM. (2008). Mu2 adaptin facilitates but is not essential for synaptic vesicle recycling in Caenorhabditis elegans . J Cell Biol , 881–892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gumienny TL, Macneil L, Zimmerman CM, Wang H, Chin L, Wrana JL, Padgett RW. (2010). Caenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. PLoS Genet, e1000963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gumienny TL, MacNeil LT, Wang H, de Bono M, Wrana JL, Padgett RW. (2007). Glypican LON-2 is a conserved negative regulator of BMP-like signaling in Caenorhabditis elegans . Curr Biol , 159–164. [DOI] [PubMed] [Google Scholar]
  20. Hill KL, Harfe BD, Dobbins CA, L’Hernault SW. (2000). dpy-18 encodes an alpha-subunit of prolyl-4-hydroxylase in Caenorhabditis elegans . Genetics , 1139–1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hodgkin J. (1983). Male phenotypes and mating efficiency in Caenorhabditis elegans . Genetics , 43–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hyun M, Kim J, Dumur C, Schroeder FC, You YJ. (2016). BLIMP-1/BLMP-1 and metastasis-associated protein regulate stress resistant development in Caenorhabditis elegans . Genetics , 1721–1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ihara Y, Inai Y, Ikezaki M, Matsui ISL, Manabe S, Ito Y. (2015). C-mannosylation: modification on tryptophan in cellular proteins. In: Glycoscience: Biology and Medicine, ed. Taniguchi N, Endo T, Hart G, Seeberger P, Wong CH, Tokyo: Springer, 1091–1099. [Google Scholar]
  24. Jackson BM, Abete-Luzi P, Krause MW, Eisenmann DM. (2014). Use of an activated beta-catenin to identify Wnt pathway target genes in Caenorhabditis elegans, including a subset of collagen genes expressed in late larval development. G3 (Bethesda) , 733–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jonckheere N, Perrais M, Mariette C, Batra SK, Aubert JP, Pigny P, Van Seuningen I. (2004a). A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-β in pancreatic carcinogenesis. Oncogene , 5729–5738. [DOI] [PubMed] [Google Scholar]
  26. Jonckheere N, Van Der Sluis M, Velghe A, Buisine MP, Sutmuller M, Ducourouble MP, Pigny P, Büller HA, Aubert JP, Einerhand AW, Van Seuningen I. (2004b). Transcriptional activation of the murine Muc5ac mucin gene in epithelial cancer cells by TGF-β/Smad4 signalling pathway is potentiated by Sp1. Biochem J , 797–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kamath RS, Ahringer J. (2003). Genome-wide RNAi screening in Caenorhabditis elegans . Methods , 313–321. [DOI] [PubMed] [Google Scholar]
  28. Kim KK, Sheppard D, Chapman HA. (2018). TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol , a022293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ko FC, Chow KL. (2002). A novel thioredoxin-like protein encoded by the C. elegans dpy-11 gene is required for body and sensory organ morphogenesis. Development , 1185–1194. [DOI] [PubMed] [Google Scholar]
  30. Kobayashi T, Gengyo-Ando K, Ishihara T, Katsura I, Mitani S. (2007). IFT-81 and IFT-74 are required for intraflagellar transport in C. elegans . Genes Cells , 593–602. [DOI] [PubMed] [Google Scholar]
  31. Krishna S, Maduzia LL, Padgett RW. (1999). Specificity of TGFβ signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans . Development , 251–260. [DOI] [PubMed] [Google Scholar]
  32. Li Q, Liu G, Shao D, Wang J, Yuan H, Chen T, Zhai R, Ni W, Tai G. (2015a). Mucin1 mediates autocrine transforming growth factor β signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells. Int J Biochem Cell Biol , 116–125. [DOI] [PubMed] [Google Scholar]
  33. Li Q, Liu G, Yuan H, Wang J, Guo Y, Chen T, Zhai R, Ni W, Tai G. (2015b). Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells. Oncotarget , 4253–4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Liang J, Lints R, Foehr ML, Tokarz R, Yu L, Emmons SW, Liu J, Savage-Dunn C. (2003). The Caenorhabditis elegans schnurri homolog sma-9 mediates stage- and cell type-specific responses to DBL-1 BMP-related signaling. Development , 6453–6464. [DOI] [PubMed] [Google Scholar]
  35. Liang J, Xiong S, Savage-Dunn C. (2013). Using RNA-mediated interference feeding strategy to screen for genes involved in body size regulation in the nematode C. elegans . J Vis Exp , 4373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Liang J, Yu L, Yin J, Savage-Dunn C. (2007). Transcriptional repressor and activator activities of SMA-9 contribute differentially to BMP-related signaling outputs. Dev Biol , 714–725. [DOI] [PubMed] [Google Scholar]
  37. Luo S, Shaw WM, Ashraf J, Murphy CT. (2009). TGF-β Sma/Mab signaling mutations uncouple reproductive aging from somatic aging. PLoS Genet , e1000789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Madaan U, Faure L, Chowdhury A, Ahmed S, Ciccarelli EJ, Gumienny TL, Savage-Dunn C. (2019). Feedback regulation of BMP signaling by C. elegans cuticle collagens bioRxiv 686592. [DOI] [PMC free article] [PubMed]
  39. Madaan U, Yzeiraj E, Meade M, Clark JF, Rushlow CA, Savage-Dunn C. (2018). BMP signaling determines body size via transcriptional regulation of collagen genes in Caenorhabditis elegans . Genetics , 1355–1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Madhu B, Salazar AE, Gumienny TL. (2019). Caenorhabditis elegans egg-laying and brood-size changes upon exposure to Serratia marcescens and Staphylococcus epidermidis are independent of DBL-1 signaling microPublication Biology, 10.17912/2r51-b476. [DOI] [PMC free article] [PubMed]
  41. Maduzia LL, Roberts AF, Wang H, Lin X, Chin LJ, Zimmerman CM, Cohen S, Feng XH, Padgett RW. (2005). C. elegans serine-threonine kinase KIN-29 modulates TGFβ signaling and regulates body size formation. BMC Dev Biol , 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mazzorana M, Gruffat H, Sergeant A, van der Rest M. (1993). Mechanisms of collagen trimer formation. Construction and expression of a recombinant minigene in HeLa cells reveals a direct effect of prolyl hydroxylation on chain assembly of type XII collagen. J Biol Chem , 3029–3032. [PubMed] [Google Scholar]
  43. Meyer BJ. (2005). X-chromosome dosage compensation. In: WormBook, ed. The C. elegans Research Community, /10.1895/wormbook.1.8.1. [DOI] [PMC free article] [PubMed]
  44. Mochii M, Yoshida S, Morita K, Kohara Y, Ueno N. (1999). Identification of transforming growth factor-β- regulated genes in Caenorhabditis elegans by differential hybridization of arrayed cDNAs. Proc Natl Acad Sci USA , 15020–15025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH, Aburatani H, Miyazono K. (2011). ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res , 8712–8727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Morita K, Chow KL, Ueno N. (1999). Regulation of body length and male tail ray pattern formation of Caenorhabditis elegans by a member of TGF-β family. Development , 1337–1347. [DOI] [PubMed] [Google Scholar]
  47. Nishiwaki K, Miwa J. (1998). Mutations in genes encoding extracellular matrix proteins suppress the emb-5 gastrulation defect in Caenorhabditis elegans . Mol Gen Genet , 2–12. [DOI] [PubMed] [Google Scholar]
  48. Nystrom J, Shen ZZ, Aili M, Flemming AJ, Leroi A, Tuck S. (2002). Increased or decreased levels of Caenorhabditis elegans lon-3, a gene encoding a collagen, cause reciprocal changes in body length. Genetics , 83–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Page AP, Johnstone IL. (2007). The cuticle. In: WormBook, ed. The C. elegans Research Community, /10.1895/wormbook.1.138.1.
  50. Paralkar VM, Nandedkar AK, Pointer RH, Kleinman HK, Reddi AH. (1990). Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem , 17281–17284. [PubMed] [Google Scholar]
  51. Paralkar VM, Weeks BS, Yu YM, Kleinman HK, Reddi AH. (1992). Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J Cell Biol , 1721–1728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Portman DS. (2006). Profiling C. elegans gene expression with DNA microarrays. WormBook, 1–11. [DOI] [PMC free article] [PubMed]
  53. Roberts AF, Gumienny TL, Gleason RJ, Wang H, Padgett RW. (2010). Regulation of genes affecting body size and innate immunity by the DBL-1/BMP-like pathway in Caenorhabditis elegans . BMC Dev Biol , 61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, Hirozane-Kishikawa T, Vandenhaute J, Orkin SH, Hill DE, van den Heuvel S, et al (2004). Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res , 2162–2168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Salehi S, Bankoti R, Benevides L, Willen J, Couse M, Silva JS, Dhall D, Meffre E, Targan S, Martins GA. (2012). Blimp-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J Immunol , 5682–5693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW. (1996). Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA , 790–794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Savage-Dunn C, Maduzia LL, Zimmerman CM, Roberts AF, Cohen S, Tokarz R, Padgett RW. (2003). Genetic screen for small body size mutants in C. elegans reveals many TGFβ pathway components. Genesis , 239–247. [DOI] [PubMed] [Google Scholar]
  58. Schertel C, Conradt B. (2007). C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions. Development , 3691–3701. [DOI] [PubMed] [Google Scholar]
  59. Schultz RD, Bennett EE, Ellis EA, Gumienny TL. (2014). Regulation of extracellular matrix organization by BMP signaling in Caenorhabditis elegans . PLoS One , e101929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Shen X, Valencia CA, Gao W, Cotten SW, Dong B, Huang BC, Liu R. (2008). Ca2+/Calmodulin-binding proteins from the C. elegans proteome. Cell Calcium , 444–456. [DOI] [PubMed] [Google Scholar]
  61. Shim J, Lee J. (2000). Molecular genetic analysis of apm-2 and aps-2, genes encoding the medium and small chains of the AP-2 clathrin-associated protein complex in the nematode Caenorhabditis elegans . Mol Cells , 309–316. [PubMed] [Google Scholar]
  62. Starich TA, Herman RK, Kari CK, Yeh WH, Schackwitz WS, Schuyler MW, Collet J, Thomas JH, Riddle DL. (1995). Mutations affecting the chemosensory neurons of Caenorhabditis elegans . Genetics , 171–188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Suzuki Y, Yandell MD, Roy PJ, Krishna S, Savage-Dunn C, Ross RM, Padgett RW, Wood WB. (1999). A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans . Development , 241–250. [DOI] [PubMed] [Google Scholar]
  64. Telerman SB, Rognoni E, Sequeira I, Pisco AO, Lichtenberger BM, Culley OJ, Viswanathan P, Driskell RR, Watt FM. (2017). Dermal Blimp1 acts downstream of epidermal TGFβ and Wnt/beta-catenin to regulate hair follicle formation and growth. J Invest Dermatol , 2270–2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Thacker C, Peters K, Srayko M, Rose AM. (1995). The bli-4 locus of Caenorhabditis elegans encodes structurally distinct kex2/subtilisin-like endoproteases essential for early development and adult morphology. Genes Dev , 956–971. [DOI] [PubMed] [Google Scholar]
  66. Timmons L, Fire A. (1998). Specific interference by ingested dsRNA. Nature , 854. [DOI] [PubMed] [Google Scholar]
  67. Torpe N, Pocock R. (2014). Regulation of axonal midline guidance by prolyl 4-hydroxylation in Caenorhabditis elegans . J Neurosci , 16348–16357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Walmsley AR, Batten MR, Lad U, Bulleid NJ. (1999). Intracellular retention of procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J Biol Chem , 14884–14892. [DOI] [PubMed] [Google Scholar]
  69. Wang X, Harris RE, Bayston LJ, Ashe HL. (2008). Type IV collagens regulate BMP signalling in Drosophila . Nature , 72–77. [DOI] [PubMed] [Google Scholar]
  70. Wicks SR, Yeh RT, Gish WR, Waterston RH, Plasterk RH. (2001). Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat Genet , 160–164. [DOI] [PubMed] [Google Scholar]
  71. Williams BD, Schrank B, Huynh C, Shownkeen R, Waterston RH. (1992). A genetic mapping system in Caenorhabditis elegans based on polymorphic sequence-tagged sites. Genetics , 609–624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Yandell MD, Edgar LG, Wood WB. (1994). Trimethylpsoralen induces small deletion mutations in Caenorhabditis elegans . Proc Natl Acad Sci USA , 1381–1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yemini E, Jucikas T, Grundy LJ, Brown AE, Schafer WR. (2013). A database of Caenorhabditis elegans behavioral phenotypes. Nat Methods , 877–879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Yonker SA, Meyer BJ. (2003). Recruitment of C. elegans dosage compensation proteins for gene-specific versus chromosome-wide repression. Development , 6519–6532. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (43.8KB, pdf)

Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES